↓ Skip to main content

Dove Medical Press

Article Metrics

Antiproliferation effect of imatinib mesylate on MCF7, T-47D tumorigenic and MCF 10A nontumorigenic breast cell lines via PDGFR-β, PDGF-BB, c-Kit and SCF genes

Overview of attention for article published in Drug Design, Development and Therapy, February 2017
Altmetric Badge

Mentioned by

twitter
1 tweeter

Citations

dimensions_citation
15 Dimensions

Readers on

mendeley
22 Mendeley
Title
Antiproliferation effect of imatinib mesylate on MCF7, T-47D tumorigenic and MCF 10A nontumorigenic breast cell lines via PDGFR-β, PDGF-BB, c-Kit and SCF genes
Published in
Drug Design, Development and Therapy, February 2017
DOI 10.2147/dddt.s124102
Pubmed ID
Authors

Ali Kadivar, Behnam Kamalidehghan, Hamid Akbari Javar, Benyamin Karimi, Reihaneh Sedghi, Mohamed Ibrahim Noordin

Twitter Demographics

The data shown below were collected from the profile of 1 tweeter who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 22 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 22 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 7 32%
Student > Bachelor 4 18%
Student > Doctoral Student 3 14%
Student > Master 3 14%
Researcher 2 9%
Other 1 5%
Unknown 2 9%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 8 36%
Pharmacology, Toxicology and Pharmaceutical Science 5 23%
Medicine and Dentistry 2 9%
Agricultural and Biological Sciences 1 5%
Chemical Engineering 1 5%
Other 0 0%
Unknown 5 23%

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 30 December 2020.
All research outputs
#17,599,537
of 19,856,719 outputs
Outputs from Drug Design, Development and Therapy
#1,383
of 1,877 outputs
Outputs of similar age
#394,063
of 469,643 outputs
Outputs of similar age from Drug Design, Development and Therapy
#6
of 6 outputs
Altmetric has tracked 19,856,719 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,877 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.4. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 469,643 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 6 others from the same source and published within six weeks on either side of this one.